Compare
EBR Systems, Inc. vs Catheter Precision, Inc. vs INVO Fertility, Inc. vs Nexgel, Inc.
| Latest fiscal year | EBR Systems, Inc. NONE. | Catheter Precision, Inc. VTAK | INVO Fertility, Inc. IVF | Nexgel, Inc. NXGL |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $1.62M | $819.0K | $6.84M | $11.42M |
| Revenue growth (YoY) | n/a | +95.0% | +4.7% | +31.5% |
| Gross margin | 30.3% | 92.3% | n/a | 39.5% |
| Operating margin | n/m | n/m | -105.8% | -29.3% |
| Net margin | n/m | n/m | -340.9% | -26.3% |
| Net income | -$48.76M | -$17.18M | -$23.32M | -$3.00M |
| EPS (Diluted) | -$0.12 | n/a | -$214.64 | -$0.38 |
| Operating cash flow | -$53.19M | -$8.30M | -$7.01M | -$1.31M |
| Free cash flow | -$56.88M | -$8.31M | -$7.06M | -$1.38M |
| Cash & equivalents | $5.79M | $88.0K | n/a | n/a |
| Total assets | $97.23M | $15.86M | $20.22M | $10.46M |
| Total liabilities | $71.64M | $9.21M | $13.00M | $5.57M |
| Shareholders' equity | $25.59M | $7.05M | $7.22M | $4.46M |
| Return on year-end equity | -190.6% | -243.6% | -322.8% | -67.3% |
| Shares outstanding | 450.26M | 1.74M | 477.4K | 8.14M |
Revenue, most recent five fiscal years
| Fiscal year | EBR Systems, Inc. | Catheter Precision, Inc. | INVO Fertility, Inc. | Nexgel, Inc. |
|---|---|---|---|---|
| Latest | $1.62M Ended 2025-12-31 | $819.0K Ended 2025-12-31 | $6.84M Ended 2025-12-31 | $11.42M Ended 2025-12-31 |
| 1 year earlier | n/a | $420.0K Ended 2024-12-31 | $6.53M Ended 2024-12-31 | $8.69M Ended 2024-12-31 |
| 2 years earlier | n/a | $442.0K Ended 2023-12-31 | $3.02M Ended 2023-12-31 | $4.09M Ended 2023-12-31 |
| 3 years earlier | n/a | $14.0K Ended 2022-12-31 | n/a | $2.05M Ended 2022-12-31 |
| 4 years earlier | n/a | $22.0K Ended 2021-12-31 | n/a | $1.55M Ended 2021-12-31 |